| May 21, 2015 | ISSUE NUMBER 401 VOL 4 |
Top Story
Health Innovation 101: Institutionalizing the Teachable Moment
William Looney reports on a meeting of a unique network of 19 US and European academic programs focused on building an inventory of shared learning and best practices in health innovation to drive reforms in both the public and private sectors
...Read more
Europe
UK Election Result: What Does It Mean for Pharma?
The dust has settled after what turned out to be, contrary to the expectations of many, a majority win by the Conservative Party in the UK's 2015 General Election. So what does this mean for industry? Leela Barham reports
...Read more
A Regulatory Dark Horse? Cross-Border Patients' Rights in Europe
The European Union's directive on patients' rights in cross-border healthcare was seen as a bit of a damp squib when it was first adopted, but its importance is now coming into view, writes Reflector
...Read more
Marketing
Cures: The New Game-Changers
With a robust clinical portfolio, ongoing promotional presence and positive patient response, historically, brands have been able to reach standard of care status and astronomical heights over time. But new cures are changing the game for everyone, writes Mike Rutstein
...Read more
Technology
Capturing the Cloud
Pharm Exec talks to Matt Wallach, President of Veeva Systems, an upstart start-up whose mix of cutting-edge technology and strong customer orientation has brought it to the top rank in providing cloud-based data management services to the industry
...Read more
How Changes in the Healthcare Environment Mean New Marketing Opportunities for Pharmaceutical Providers
As the healthcare industry undergoes significant change, physicians and other healthcare providers are forced to find new ways to stay informed and meet increased demands. To help them, their circle of influence has widened, including digital sources, social media, online forums, traditional journal articles by key opinion leaders, and even the patients themselves. Meanwhile, pharmaceutical companies are looking for new opportunities of their own to help get their products in front of a new generation of healthcare providers. Discover the right tools to help do it.
 Click here
|
|
|
 //CutisPharma (Wilmington, MA) named President Neal Muni, MD, MSPH to the role of Chief Executive Officer. //Minerva Neurosciences (Waltham, MA) appointed Fouzia Laghrissi-Thode, M.D. to its Board of Directors. //Otonomy (San Diego, CA) appointed Eric Loumeau as General Counsel and Chief Compliance Officer. //Lipocine (Salt Lake City, UT) appointed Jyrki Mattila, M.D., Ph.D., M.B.A to the newly created position of Executive Vice President and Chief Business Officer. //Amgen (Thousand Oaks, CA) announced the appointment of Jonathan P. Graham as Senior Vice President, General Counsel and Secretary, effective July 13, 2015. // |
|
Hiding in Plain Slight
Co-pay as the key to Patient engagement?
Live Webcast: Thursday, May 21th, 2015 at 2:00 PM
How CoPay Programs can Increase Patient Engagement - What Your CoPay Program Should be Delivering for you.
 Register for free
|
|
|
|
|
